| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | small GTPase binding | RANBP2 ABCA1 MYO1C ERC1 ANXA2 ANXA2P2 DOCK9 RABGAP1 FMNL2 HPS4 FGD1 | 3.84e-05 | 321 | 153 | 11 | GO:0031267 |
| GeneOntologyMolecularFunction | cargo receptor activity | 4.87e-05 | 85 | 153 | 6 | GO:0038024 | |
| GeneOntologyMolecularFunction | bone sialoprotein binding | 5.83e-05 | 2 | 153 | 2 | GO:0044730 | |
| GeneOntologyMolecularFunction | GTPase binding | RANBP2 ABCA1 MYO1C ERC1 ANXA2 ANXA2P2 DOCK9 RABGAP1 FMNL2 HPS4 FGD1 | 1.07e-04 | 360 | 153 | 11 | GO:0051020 |
| GeneOntologyMolecularFunction | phospholipase A2 inhibitor activity | 5.75e-04 | 5 | 153 | 2 | GO:0019834 | |
| GeneOntologyMolecularFunction | hemoglobin alpha binding | 5.75e-04 | 5 | 153 | 2 | GO:0031721 | |
| GeneOntologyBiologicalProcess | intracellular transport | RANBP2 ABCA1 MYH10 STBD1 AFTPH MYO1C ERC1 ANXA2 ANXA2P2 CEP290 COPB2 KLC2 LMTK2 HEATR5A VPS36 CCDC38 LYST MDN1 MIA2 STXBP3 PIK3C3 DAW1 HPS4 CTAGE1 SYNE2 EDEM2 RBM15B VPS13B EXOC4 PCNT | 4.23e-07 | 1496 | 152 | 30 | GO:0046907 |
| GeneOntologyBiologicalProcess | secretory granule organization | 2.41e-05 | 78 | 152 | 6 | GO:0033363 | |
| GeneOntologyBiologicalProcess | organelle assembly | MYH10 STBD1 CENPF CNTRL CEP290 VPS36 CEP192 RABGAP1 RB1CC1 CCDC38 PFN4 MDN1 PIK3C3 DAW1 NISCH HPS4 SYNE2 ULK4 CEP152 PRKDC VPS13B PCNT | 3.18e-05 | 1138 | 152 | 22 | GO:0070925 |
| GeneOntologyBiologicalProcess | positive regulation of low-density lipoprotein particle receptor binding | 5.40e-05 | 2 | 152 | 2 | GO:1905597 | |
| GeneOntologyBiologicalProcess | centrosome-templated microtubule nucleation | 5.40e-05 | 2 | 152 | 2 | GO:0090222 | |
| GeneOntologyBiologicalProcess | blastocyst development | 5.57e-05 | 179 | 152 | 8 | GO:0001824 | |
| GeneOntologyBiologicalProcess | vacuole organization | 9.88e-05 | 249 | 152 | 9 | GO:0007033 | |
| GeneOntologyBiologicalProcess | microtubule-based process | CLIP2 CNTRL CEP290 OR4M1 KLC2 CDK11A CEP192 CCDC38 LYST PFN4 DAW1 NISCH SYNE2 ULK4 TAC3 CEP152 DNAH9 PCNT WDR72 NIN | 1.02e-04 | 1058 | 152 | 20 | GO:0007017 |
| GeneOntologyBiologicalProcess | centrosome localization | 1.24e-04 | 35 | 152 | 4 | GO:0051642 | |
| GeneOntologyBiologicalProcess | microtubule organizing center localization | 1.39e-04 | 36 | 152 | 4 | GO:0061842 | |
| GeneOntologyBiologicalProcess | positive regulation of receptor-mediated endocytosis involved in cholesterol transport | 1.61e-04 | 3 | 152 | 2 | GO:1905602 | |
| GeneOntologyBiologicalProcess | negative regulation of low-density lipoprotein particle receptor catabolic process | 1.61e-04 | 3 | 152 | 2 | GO:0032804 | |
| GeneOntologyBiologicalProcess | cerebral cortex radially oriented cell migration | 2.55e-04 | 42 | 152 | 4 | GO:0021799 | |
| GeneOntologyBiologicalProcess | vesicle organization | ABCA1 ERC1 ANXA2 VPS36 CCDC38 LYST PFN4 PIK3C3 HPS4 VPS13B WDR72 | 2.62e-04 | 415 | 152 | 11 | GO:0016050 |
| GeneOntologyBiologicalProcess | positive regulation of low-density lipoprotein particle clearance | 3.21e-04 | 4 | 152 | 2 | GO:1905581 | |
| GeneOntologyBiologicalProcess | negative regulation of receptor catabolic process | 3.21e-04 | 4 | 152 | 2 | GO:2000645 | |
| GeneOntologyBiologicalProcess | proteasomal ubiquitin-independent protein catabolic process | 3.21e-04 | 4 | 152 | 2 | GO:0010499 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular cholesterol transport | 3.21e-04 | 4 | 152 | 2 | GO:0032385 | |
| GeneOntologyBiologicalProcess | positive regulation of intracellular sterol transport | 3.21e-04 | 4 | 152 | 2 | GO:0032382 | |
| GeneOntologyCellularComponent | pericentriolar material | 4.93e-05 | 28 | 153 | 4 | GO:0000242 | |
| GeneOntologyCellularComponent | microtubule organizing center | CENPF ERC1 CNTRL CEP290 CEP192 RABGAP1 CCDC92 CCDC141 CCDC38 SPECC1 CEP78 NFE2L2 DAW1 ZFYVE26 CEP152 EXOC4 PCNT NIN | 1.39e-04 | 919 | 153 | 18 | GO:0005815 |
| GeneOntologyCellularComponent | procentriole | 1.59e-04 | 3 | 153 | 2 | GO:0120098 | |
| GeneOntologyCellularComponent | AnxA2-p11 complex | 1.59e-04 | 3 | 153 | 2 | GO:1990665 | |
| GeneOntologyCellularComponent | PCSK9-AnxA2 complex | 1.59e-04 | 3 | 153 | 2 | GO:1990667 | |
| GeneOntologyCellularComponent | centrosome | CENPF ERC1 CNTRL CEP290 CEP192 RABGAP1 CCDC92 CCDC141 CCDC38 CEP78 NFE2L2 ZFYVE26 CEP152 EXOC4 PCNT NIN | 1.71e-04 | 770 | 153 | 16 | GO:0005813 |
| GeneOntologyCellularComponent | midbody | 2.36e-04 | 222 | 153 | 8 | GO:0030496 | |
| GeneOntologyCellularComponent | transferase complex | RANBP2 ERC1 POLR2C CDK11A RB1CC1 PRAMEF1 PRAMEF13 VIRMA PIK3C2A PIK3C3 ANAPC1 DAW1 PRAMEF14 RBM15B PRKDC WDR41 WDFY3 MGA | 2.46e-04 | 963 | 153 | 18 | GO:1990234 |
| GeneOntologyCellularComponent | centriole | 2.80e-04 | 172 | 153 | 7 | GO:0005814 | |
| GeneOntologyCellularComponent | cilium | EFCAB6 CENPF ERC1 CNTRL CEP290 KLC2 PRAMEF1 PRAMEF13 CCDC38 ARR3 CEP78 PIK3C3 DAW1 ULK4 DNAH9 PCNT NIN | 3.19e-04 | 898 | 153 | 17 | GO:0005929 |
| GeneOntologyCellularComponent | procentriole replication complex | 7.83e-04 | 6 | 153 | 2 | GO:0120099 | |
| GeneOntologyCellularComponent | myelin sheath adaxonal region | 1.09e-03 | 7 | 153 | 2 | GO:0035749 | |
| GeneOntologyCellularComponent | nuclear membrane | 1.10e-03 | 349 | 153 | 9 | GO:0031965 | |
| GeneOntologyCellularComponent | vacuolar membrane | ANXA2 ANXA2P2 KLC2 RB1CC1 TLR8 ARRB1 HPS4 ZFYVE26 WDR41 WDFY3 VPS13B | 1.30e-03 | 507 | 153 | 11 | GO:0005774 |
| GeneOntologyCellularComponent | cell cortex | 1.68e-03 | 371 | 153 | 9 | GO:0005938 | |
| GeneOntologyCellularComponent | RNA N6-methyladenosine methyltransferase complex | 1.85e-03 | 9 | 153 | 2 | GO:0036396 | |
| GeneOntologyCellularComponent | Atg1/ULK1 kinase complex | 1.85e-03 | 9 | 153 | 2 | GO:1990316 | |
| Domain | ARM-type_fold | DOCK9 INTS1 HEATR5A FMNL2 TRIP12 VIRMA LYST NCAPG2 RIF1 PIK3C2A PIK3C3 RRP12 ULK4 PRKDC WDFY3 PPP6R3 TANGO6 | 1.66e-09 | 339 | 148 | 17 | IPR016024 |
| Domain | Prefoldin | 2.27e-05 | 72 | 148 | 6 | IPR009053 | |
| Domain | Pentatricopeptide_repeat | 2.98e-05 | 23 | 148 | 4 | IPR002885 | |
| Domain | - | CNTRL LRRC2 PRAMEF1 PRAMEF13 TLR8 CEP78 NISCH TLR1 LRRC14 LRRC17 NLRP13 | 5.14e-05 | 321 | 148 | 11 | 3.80.10.10 |
| Domain | ARM-like | HEATR5A TRIP12 NCAPG2 RIF1 RRP12 ULK4 PRKDC WDFY3 PPP6R3 TANGO6 | 5.97e-05 | 270 | 148 | 10 | IPR011989 |
| Domain | L_dom-like | CNTRL LRRC2 PRAMEF1 PRAMEF13 TLR8 CEP78 NISCH TLR1 LRRC14 LRRC17 NLRP13 | 6.24e-05 | 328 | 148 | 11 | IPR032675 |
| Domain | - | 7.07e-05 | 222 | 148 | 9 | 1.25.10.10 | |
| Domain | WD40_repeat_dom | 1.31e-04 | 297 | 148 | 10 | IPR017986 | |
| Domain | PI3/4_kinase_CS | 2.07e-04 | 15 | 148 | 3 | IPR018936 | |
| Domain | HEAT_REPEAT | 2.34e-04 | 70 | 148 | 5 | PS50077 | |
| Domain | - | 2.53e-04 | 16 | 148 | 3 | 1.10.1070.11 | |
| Domain | PI3Kc | 2.53e-04 | 16 | 148 | 3 | SM00146 | |
| Domain | WD40 | 2.91e-04 | 268 | 148 | 9 | SM00320 | |
| Domain | Leu-rich_rpt | 3.16e-04 | 271 | 148 | 9 | IPR001611 | |
| Domain | WD40_repeat | 3.25e-04 | 272 | 148 | 9 | IPR001680 | |
| Domain | - | 3.29e-04 | 333 | 148 | 10 | 2.130.10.10 | |
| Domain | WD40_repeat_CS | 3.36e-04 | 164 | 148 | 7 | IPR019775 | |
| Domain | WD40/YVTN_repeat-like_dom | 3.45e-04 | 335 | 148 | 10 | IPR015943 | |
| Domain | PI3_PI4_kinase | 3.65e-04 | 18 | 148 | 3 | PF00454 | |
| Domain | PI3_4_KINASE_1 | 3.65e-04 | 18 | 148 | 3 | PS00915 | |
| Domain | PI3_4_KINASE_2 | 3.65e-04 | 18 | 148 | 3 | PS00916 | |
| Domain | PI3/4_kinase_cat_dom | 3.65e-04 | 18 | 148 | 3 | IPR000403 | |
| Domain | PI3_4_KINASE_3 | 3.65e-04 | 18 | 148 | 3 | PS50290 | |
| Domain | Arrestin_N | 3.70e-04 | 4 | 148 | 2 | IPR014753 | |
| Domain | Arrestin_CS | 3.70e-04 | 4 | 148 | 2 | IPR017864 | |
| Domain | ARRESTINS | 3.70e-04 | 4 | 148 | 2 | PS00295 | |
| Domain | Arrestin | 3.70e-04 | 4 | 148 | 2 | IPR000698 | |
| Domain | - | 3.70e-04 | 4 | 148 | 2 | 2.60.40.840 | |
| Domain | WD_REPEATS_1 | 3.81e-04 | 278 | 148 | 9 | PS00678 | |
| Domain | WD_REPEATS_2 | 3.91e-04 | 279 | 148 | 9 | PS50082 | |
| Domain | WD_REPEATS_REGION | 3.91e-04 | 279 | 148 | 9 | PS50294 | |
| Domain | Haemoglobin_b | 6.14e-04 | 5 | 148 | 2 | IPR002337 | |
| Domain | Quinoprotein_ADH-like_supfam | 8.20e-04 | 53 | 148 | 4 | IPR011047 | |
| Domain | PH_BEACH | 9.16e-04 | 6 | 148 | 2 | PF14844 | |
| Domain | WD40 | 1.09e-03 | 259 | 148 | 8 | PF00400 | |
| Domain | - | 1.28e-03 | 7 | 148 | 2 | 2.60.40.640 | |
| Domain | FYVE | 1.53e-03 | 29 | 148 | 3 | PF01363 | |
| Domain | FYVE | 1.53e-03 | 29 | 148 | 3 | SM00064 | |
| Domain | Arrestin_C | 1.69e-03 | 8 | 148 | 2 | IPR014752 | |
| Domain | PI3K_C2 | 1.69e-03 | 8 | 148 | 2 | SM00142 | |
| Domain | PH-BEACH_dom | 1.69e-03 | 8 | 148 | 2 | IPR023362 | |
| Domain | PI3K_C2_dom | 1.69e-03 | 8 | 148 | 2 | IPR002420 | |
| Domain | - | 1.69e-03 | 8 | 148 | 2 | 2.30.29.40 | |
| Domain | PI3K_C2 | 1.69e-03 | 8 | 148 | 2 | PF00792 | |
| Domain | PI3K_C2 | 1.69e-03 | 8 | 148 | 2 | PS51547 | |
| Domain | PH_BEACH | 1.69e-03 | 8 | 148 | 2 | PS51783 | |
| Domain | LRR_1 | 1.83e-03 | 219 | 148 | 7 | PF00560 | |
| Domain | PI3Ka | 2.16e-03 | 9 | 148 | 2 | PF00613 | |
| Domain | BEACH | 2.16e-03 | 9 | 148 | 2 | PS50197 | |
| Domain | Beach | 2.16e-03 | 9 | 148 | 2 | PF02138 | |
| Domain | - | 2.16e-03 | 9 | 148 | 2 | 1.10.1540.10 | |
| Domain | Beach | 2.16e-03 | 9 | 148 | 2 | SM01026 | |
| Domain | PI3Ka | 2.16e-03 | 9 | 148 | 2 | SM00145 | |
| Domain | BEACH_dom | 2.16e-03 | 9 | 148 | 2 | IPR000409 | |
| Domain | - | 2.16e-03 | 9 | 148 | 2 | 1.25.40.70 | |
| Domain | Znf_FYVE-rel | 2.44e-03 | 34 | 148 | 3 | IPR017455 | |
| Domain | Arrestin-like_N | 2.69e-03 | 10 | 148 | 2 | IPR011021 | |
| Domain | Arrestin_C-like | 2.69e-03 | 10 | 148 | 2 | IPR011022 | |
| Domain | Arrestin_C | 2.69e-03 | 10 | 148 | 2 | SM01017 | |
| Domain | PI_Kinase | 2.69e-03 | 10 | 148 | 2 | IPR015433 | |
| Domain | PInositide-3_kin_accessory_dom | 2.69e-03 | 10 | 148 | 2 | IPR001263 | |
| Domain | Arrestin_C | 2.69e-03 | 10 | 148 | 2 | PF02752 | |
| Domain | Arrestin_N | 2.69e-03 | 10 | 148 | 2 | PF00339 | |
| Domain | PIK_HELICAL | 2.69e-03 | 10 | 148 | 2 | PS51545 | |
| Domain | Znf_FYVE | 3.36e-03 | 38 | 148 | 3 | IPR000306 | |
| Domain | Myosin_head_motor_dom | 3.36e-03 | 38 | 148 | 3 | IPR001609 | |
| Domain | MYOSIN_MOTOR | 3.36e-03 | 38 | 148 | 3 | PS51456 | |
| Domain | Myosin_head | 3.36e-03 | 38 | 148 | 3 | PF00063 | |
| Domain | MYSc | 3.36e-03 | 38 | 148 | 3 | SM00242 | |
| Domain | ZF_FYVE | 3.89e-03 | 40 | 148 | 3 | PS50178 | |
| Domain | JAMM/MPN+_dom | 3.91e-03 | 12 | 148 | 2 | IPR000555 | |
| Domain | Globin | 3.91e-03 | 12 | 148 | 2 | IPR000971 | |
| Domain | WWE | 3.91e-03 | 12 | 148 | 2 | PF02825 | |
| Domain | WWE-dom | 3.91e-03 | 12 | 148 | 2 | IPR004170 | |
| Domain | WWE | 3.91e-03 | 12 | 148 | 2 | PS50918 | |
| Domain | JAB_MPN | 3.91e-03 | 12 | 148 | 2 | SM00232 | |
| Domain | JAB | 3.91e-03 | 12 | 148 | 2 | PF01398 | |
| Domain | Globin | 3.91e-03 | 12 | 148 | 2 | PF00042 | |
| Domain | GLOBIN | 3.91e-03 | 12 | 148 | 2 | PS01033 | |
| Domain | ANX | 4.59e-03 | 13 | 148 | 2 | SM00335 | |
| Domain | Annexin_repeat_CS | 4.59e-03 | 13 | 148 | 2 | IPR018252 | |
| Domain | Annexin | 4.59e-03 | 13 | 148 | 2 | PF00191 | |
| Domain | Annexin_repeat | 4.59e-03 | 13 | 148 | 2 | IPR018502 | |
| Domain | ANNEXIN | 4.59e-03 | 13 | 148 | 2 | PS00223 | |
| Domain | - | 4.59e-03 | 13 | 148 | 2 | 1.10.490.10 | |
| Domain | - | 4.59e-03 | 13 | 148 | 2 | 1.10.220.10 | |
| Domain | Globin/Proto | 4.59e-03 | 13 | 148 | 2 | IPR012292 | |
| Domain | G-protein_beta_WD-40_rep | 4.67e-03 | 85 | 148 | 4 | IPR020472 | |
| Domain | Annexin | 5.33e-03 | 14 | 148 | 2 | IPR001464 | |
| Domain | ATPase_dyneun-rel_AAA | 5.33e-03 | 14 | 148 | 2 | IPR011704 | |
| Domain | AAA_5 | 5.33e-03 | 14 | 148 | 2 | PF07728 | |
| Domain | LRR | 5.37e-03 | 201 | 148 | 6 | PS51450 | |
| Domain | Myosin_N | 6.12e-03 | 15 | 148 | 2 | PF02736 | |
| Domain | Myosin_N | 6.12e-03 | 15 | 148 | 2 | IPR004009 | |
| Domain | Globin-like | 6.96e-03 | 16 | 148 | 2 | IPR009050 | |
| Pathway | REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES | 1.89e-06 | 81 | 102 | 7 | M748 | |
| Pathway | REACTOME_AURKA_ACTIVATION_BY_TPX2 | 1.31e-05 | 72 | 102 | 6 | M27749 | |
| Pathway | REACTOME_MITOTIC_G2_G2_M_PHASES | 1.43e-05 | 200 | 102 | 9 | M864 | |
| Pathway | REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION | 3.89e-05 | 87 | 102 | 6 | M27194 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 6.39e-05 | 95 | 102 | 6 | M6729 | |
| Pathway | REACTOME_ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE | 7.18e-05 | 97 | 102 | 6 | M27478 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 1.15e-04 | 204 | 102 | 8 | M4217 | |
| Pathway | REACTOME_CELL_CYCLE | RANBP2 CENPF CNTRL POLR2C CEP290 CDK11A PSMD7 CEP192 NCAPG2 CEP78 ANAPC1 SYNE2 CEP152 PPP6R3 PCNT | 1.34e-04 | 694 | 102 | 15 | M543 |
| Pathway | REACTOME_M_PHASE | RANBP2 CENPF CNTRL CEP290 PSMD7 CEP192 NCAPG2 CEP78 ANAPC1 CEP152 PCNT | 2.11e-04 | 417 | 102 | 11 | M27662 |
| Pubmed | SHANK1 RANBP2 MYH10 CLIP2 CNTRL CEP290 LAMB1 CCDC92 FMNL2 MKNK1 RIF1 ARRB1 TLE5 N4BP2 HPS4 PRKDC NOSTRIN MGA | 7.76e-12 | 486 | 155 | 18 | 20936779 | |
| Pubmed | RANBP2 MYH10 MYO1C CENPF COPB2 INTS1 NOL11 GEMIN5 NOL10 TRIP12 VIRMA RIF1 MDN1 ANAPC1 RRP12 SYNE2 PRKDC PPP6R3 PCNT ZC3HAV1 | 1.54e-11 | 653 | 155 | 20 | 22586326 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | UAP1 SHROOM3 AFTPH ERC1 KLC2 LMTK2 PSMD7 CEP192 SPECC1 TRIP12 VIRMA LYST MDN1 PIK3C2A PIK3C3 N4BP2 SYNE2 TET1 CEP152 RNF180 EXOC4 ZC3HAV1 | 4.53e-11 | 861 | 155 | 22 | 36931259 |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | CENPF ANXA2 COPB2 MRPS27 NOL11 NOL10 TRIP12 VIRMA RIF1 MDN1 CEP78 PIK3C3 RRP12 RBM15B PRKDC UTP3 EIF3H NOL8 EXOC4 ZC3HAV1 | 2.18e-10 | 759 | 155 | 20 | 35915203 |
| Pubmed | SHROOM3 STBD1 AFTPH MRPS27 NOL11 LAMB1 PSMD7 CEP192 RB1CC1 NCAPG2 MDN1 SARS1 STXBP3 PIK3C2A N4BP2 NISCH RRP12 SYNE2 MTR WDR41 VPS13B PPP6R3 NOL8 EXOC4 PCNT ZC3HAV1 NIN | 5.03e-10 | 1487 | 155 | 27 | 33957083 | |
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | RANBP2 SHROOM3 MYH10 AFTPH ERC1 ANXA2 CNTRL CEP290 KLC2 CEP192 LRP1B STXBP3 N4BP2 CEP152 MGA PPP6R3 EXOC4 PCNT ZC3HAV1 NIN | 1.63e-09 | 853 | 155 | 20 | 28718761 |
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | RANBP2 MYH10 MYO1C CENPF ANXA2 COPB2 MRPS27 NOL11 GEMIN5 PSMD7 NOL10 COPS3 CCDC38 RIF1 MDN1 SARS1 STXBP3 ANAPC1 RRP12 RBM15B MTR PRKDC UTP3 EIF3H ZC3HAV1 | 4.77e-09 | 1425 | 155 | 25 | 30948266 |
| Pubmed | RANBP2 MYH10 MYO1C CENPF ERC1 ANXA2 CNTRL DACT2 PSMD7 VPS36 TRIP12 LYST SCML4 ARRB1 MDN1 MIA2 N4BP2 CTAGE1 CHD5 SYNE2 MYH15 PRKDC NOSTRIN CCDC89 PCNT | 6.04e-09 | 1442 | 155 | 25 | 35575683 | |
| Pubmed | RANBP2 ZNF609 CENPF ERC1 GEMIN5 RABGAP1 RB1CC1 ANAPC1 N4BP2 TET1 MGA EXOC4 TANGO6 PCNT | 6.58e-09 | 418 | 155 | 14 | 34709266 | |
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | CENPF DOCK9 PCDHB9 MRPS27 KLC2 CDK11A PSMD7 VPS36 COPS3 TRIP12 MIDN MDN1 SARS1 RRP12 UTP3 | 7.50e-09 | 497 | 155 | 15 | 36774506 |
| Pubmed | RANBP2 MYH10 ZNF609 MYO1C ERC1 POLR2C CEP290 COPB2 LMTK2 PSMD7 NOL10 CEP192 RB1CC1 RIF1 STXBP3 RRP12 SYNE2 UTP3 PPP6R3 PCNT NIN | 9.86e-09 | 1049 | 155 | 21 | 27880917 | |
| Pubmed | RANBP2 SHROOM3 AFTPH POLR2C INTS1 MRPS27 NOL11 GEMIN5 CDK11A NOL10 SPECC1 VIRMA LGALS8 RIF1 ARRB1 MDN1 PIK3C2A ANAPC1 RRP12 RBM15B UTP3 EIF3H PPP6R3 NOL8 ZC3HAV1 | 1.27e-08 | 1497 | 155 | 25 | 31527615 | |
| Pubmed | RANBP2 MYO1C ANXA2 DOCK9 CNTRL CEP290 INTS1 KLC2 GEMIN5 PSMD7 NCAPG2 LGALS8 MDN1 MIA2 PIK3C2A PIK3C3 NISCH CHD5 PRKDC EIF3H EXOC4 PCNT | 1.27e-08 | 1168 | 155 | 22 | 19946888 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | RANBP2 AFTPH MYO1C NELFA KLC2 GEMIN5 CDK11A TRIP12 VIRMA RIF1 MDN1 ANAPC1 RRP12 RBM15B PRKDC ANXA9 PPP6R3 ZC3HAV1 | 1.28e-08 | 774 | 155 | 18 | 15302935 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | RANBP2 ZNF609 ERC1 DDX60 COPB2 NOL11 GEMIN5 TRIP12 SARS1 CEP78 PIK3C2A ANAPC1 EIF3H MGA NOL8 EXOC4 ZC3HAV1 | 2.90e-08 | 724 | 155 | 17 | 36232890 |
| Pubmed | RANBP2 ANXA2 DDX60 INTS1 STK38 TRIP12 RIF1 MDN1 ANAPC1 PRKDC MGA | 4.38e-08 | 272 | 155 | 11 | 31010829 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | MYH10 MYO1C CENPF ERC1 ANXA2 DDX60 POLR2C MRPS27 NOL11 NOL10 SPECC1 TRIP12 VIRMA LGALS8 CHD5 RRP12 RBM15B PRKDC UTP3 EIF3H NOL8 ZC3HAV1 | 4.63e-08 | 1257 | 155 | 22 | 36526897 |
| Pubmed | MYH10 ZNF609 MYO1C COPB2 MRPS27 CDK11A PSMD7 CEP192 RIF1 MIDN TLE5 CHD5 RRP12 SYNE2 MTR CEP152 EIF3H MGA PPP6R3 EXOC4 TANGO6 ZC3HAV1 SENP5 | 1.00e-07 | 1429 | 155 | 23 | 35140242 | |
| Pubmed | RANBP2 MYO1C POLR2C COPB2 PSMD7 RIF1 MDN1 SARS1 ANAPC1 RRP12 MTR WDR41 UTP3 PPP6R3 ZC3HAV1 | 1.01e-07 | 606 | 155 | 15 | 36538041 | |
| Pubmed | The PITSLRE/CDK11p58 protein kinase promotes centrosome maturation and bipolar spindle formation. | 2.14e-07 | 57 | 155 | 6 | 16462731 | |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | MYH10 STBD1 MYO1C CENPF MRPS27 NOL11 PSMD7 NOL10 RABGAP1 MDN1 SARS1 MIA2 PIK3C2A NISCH RRP12 SYNE2 MTR WDR41 UTP3 VPS13B EXOC4 PCNT ZC3HAV1 | 2.26e-07 | 1496 | 155 | 23 | 32877691 |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | MYH10 MYO1C ANXA2 ANXA2P2 CNTRL CEP290 NOL10 PRAMEF1 PRAMEF13 PRAMEF14 NISCH PRKDC QDPR EXOC4 | 2.65e-07 | 564 | 155 | 14 | 21565611 |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | RANBP2 ZNF609 CENPF ANXA2 POLR2C CEP290 INTS1 NOL11 NOL10 TRIP12 RIF1 MDN1 ANAPC1 NFE2L2 RRP12 RBM15B TIGD5 PRKDC MGA NOL8 ZC3HAV1 | 3.35e-07 | 1294 | 155 | 21 | 30804502 |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 3.40e-07 | 202 | 155 | 9 | 33005030 | |
| Pubmed | RANBP2 AFTPH CENPF NELFA ERC1 KLC2 GEMIN5 TRIP12 RIF1 RRP12 PPP6R3 EXOC4 ZC3HAV1 | 4.59e-07 | 503 | 155 | 13 | 16964243 | |
| Pubmed | 4.72e-07 | 210 | 155 | 9 | 16565220 | ||
| Pubmed | RANBP2 MYH10 MYO1C DDX60 COPB2 MRPS27 LAMB1 GEMIN5 PSMD7 COPS3 SPECC1 NCAPG2 MDN1 PIK3C2A TNFSF13B RRP12 SYNE2 PRKDC EIF3H PPP6R3 EXOC4 ZC3HAV1 | 4.74e-07 | 1440 | 155 | 22 | 30833792 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | RANBP2 MYH10 MYO1C POLR2C COPB2 NOL11 GEMIN5 PSMD7 NOL10 COPS3 TRIP12 NCAPG2 RIF1 MDN1 PIK3C2A RRP12 PRKDC WDFY3 MGA EXOC4 ZC3HAV1 | 6.88e-07 | 1353 | 155 | 21 | 29467282 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | RANBP2 MYO1C ANXA2 ANXA2P2 POLR2C COPB2 INTS1 NOL11 PSMD7 NCAPG2 RIF1 MIDN MDN1 STXBP3 ANAPC1 MTR LRRC14 PRKDC WDR41 PPP6R3 | 8.88e-07 | 1257 | 155 | 20 | 37317656 |
| Pubmed | A SARS-CoV-2 protein interaction map reveals targets for drug repurposing. | 1.01e-06 | 298 | 155 | 10 | 32353859 | |
| Pubmed | RANBP2 MYH10 COPB2 NOL11 GEMIN5 PSMD7 RIF1 MDN1 SARS1 PRKDC EIF3H PPP6R3 EXOC4 ZC3HAV1 | 1.15e-06 | 638 | 155 | 14 | 33239621 | |
| Pubmed | Large-scale mapping of human protein-protein interactions by mass spectrometry. | RANBP2 MYH10 MYO1C ERC1 ANXA2 COPB2 KLC2 PSMD7 COPS3 RB1CC1 ARR3 ARRB1 SARS1 TLE5 PIK3C3 RRP12 MTR EIF3H HBG1 EXOC4 | 1.23e-06 | 1284 | 155 | 20 | 17353931 |
| Pubmed | SHANK1 CLIP2 ERC1 POLR2C CEP290 LAMB1 PSMD7 SPECC1 FMNL2 TRIP12 LRP1B ARRB1 MIA2 NFE2L2 NISCH HPS4 PRKDC WDFY3 EXOC4 PCNT | 1.24e-06 | 1285 | 155 | 20 | 35914814 | |
| Pubmed | RANBP2 MYH10 MYO1C CLIP2 MRPS27 NOL11 NOL10 TRIP12 RIF1 MDN1 RRP12 RBM15B PRKDC UTP3 NOL8 ZC3HAV1 | 1.36e-06 | 847 | 155 | 16 | 35850772 | |
| Pubmed | Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms. | ZNF609 CENPF ERC1 CNTRL CEP290 MRPS27 NOL10 MDN1 STXBP3 TLE5 EIF3H QSOX2 NOL8 PCNT NIN | 1.57e-06 | 754 | 155 | 15 | 33060197 |
| Pubmed | WDR76 Co-Localizes with Heterochromatin Related Proteins and Rapidly Responds to DNA Damage. | RANBP2 MYH10 INTS1 NOL10 TRIP12 RIF1 MDN1 ANAPC1 RRP12 PRKDC EXOC4 | 1.73e-06 | 394 | 155 | 11 | 27248496 |
| Pubmed | DOCK9 CNTRL COPB2 LMTK2 NOL11 GEMIN5 CEP192 PRAMEF1 PRAMEF13 TRIP12 EML5 PRAMEF14 TET1 MGA QSOX2 VPS13B LRRC17 PCNT | 1.80e-06 | 1084 | 155 | 18 | 11544199 | |
| Pubmed | HAPSTR1 localizes HUWE1 to the nucleus to limit stress signaling pathways. | RANBP2 ANXA2 POLR2C COPB2 PSMD7 COPS3 STXBP3 ANAPC1 NFE2L2 RRP12 MTR PRKDC PPP6R3 | 1.88e-06 | 571 | 155 | 13 | 37167062 |
| Pubmed | RANBP2 MYO1C STK38 PSMD7 COPS3 SPECC1 TRIP12 MDN1 MIA2 PRKDC PPP6R3 | 1.95e-06 | 399 | 155 | 11 | 37536630 | |
| Pubmed | Direct interaction between hnRNP-M and CDC5L/PLRG1 proteins affects alternative splice site choice. | RANBP2 SHROOM3 COPB2 INTS1 VPS36 COPS3 TRIP12 RIF1 MDN1 ANAPC1 PRKDC EXOC4 PCNT | 2.31e-06 | 582 | 155 | 13 | 20467437 |
| Pubmed | Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability. | ERC1 POLR2C KLC2 CDK11A CEP192 RABGAP1 ANAPC1 N4BP2 MTR PPP6R3 EXOC4 PCNT NIN | 2.59e-06 | 588 | 155 | 13 | 38580884 |
| Pubmed | Fibril treatment changes protein interactions of tau and α-synuclein in human neurons. | MYH10 MYO1C CENPF ANXA2 INTS1 MRPS27 KLC2 TRIP12 STXBP3 RRP12 SYNE2 PPP6R3 | 2.66e-06 | 498 | 155 | 12 | 36634849 |
| Pubmed | ZNF609 MYO1C ERC1 POLR2C LAMB1 GPR108 FMNL2 EML5 ANAPC1 TNFSF13B CHD5 MTR TIGD5 WDFY3 MGA QSOX2 WDR72 NIN | 2.70e-06 | 1116 | 155 | 18 | 31753913 | |
| Pubmed | 3.28e-06 | 340 | 155 | 10 | 29478914 | ||
| Pubmed | 3.74e-06 | 202 | 155 | 8 | 24639526 | ||
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | SHROOM3 ZNF609 STBD1 AFTPH CCDC141 TRIP12 MIA2 NFE2L2 CHD5 MGA PCNT | 3.99e-06 | 430 | 155 | 11 | 35044719 |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | RANBP2 ZNF609 CENPF COPB2 STK38 LAMB1 COPS3 CEP192 SPECC1 ARRB1 CEP78 ANAPC1 RRP12 CEP152 PRKDC EIF3H VPS13B EXOC4 | 4.34e-06 | 1155 | 155 | 18 | 20360068 |
| Pubmed | 4.40e-06 | 146 | 155 | 7 | 21399614 | ||
| Pubmed | STBD1 ERC1 COPB2 RABGAP1 RB1CC1 RIF1 SARS1 CEP78 PIK3C2A PIK3C3 PRKDC | 4.65e-06 | 437 | 155 | 11 | 20562859 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | RANBP2 POLR2C LMTK2 GEMIN5 TRIP12 ANAPC1 NISCH RRP12 UTP3 PPP6R3 ZC3HAV1 | 4.97e-06 | 440 | 155 | 11 | 34244565 |
| Pubmed | The centrosomal protein C-Nap1 is required for cell cycle-regulated centrosome cohesion. | 5.24e-06 | 56 | 155 | 5 | 11076968 | |
| Pubmed | Proteomic characterization of the human centrosome by protein correlation profiling. | 5.26e-06 | 26 | 155 | 4 | 14654843 | |
| Pubmed | Mapping the Ku Interactome Using Proximity-Dependent Biotin Identification in Human Cells. | 5.49e-06 | 283 | 155 | 9 | 30585729 | |
| Pubmed | SHROOM3 NELFA ERC1 KLC2 CEP192 PIK3C2A ANAPC1 CEP152 PRKDC PPP6R3 NIN | 5.64e-06 | 446 | 155 | 11 | 24255178 | |
| Pubmed | Transcriptome analysis of mouse stem cells and early embryos. | ABCA1 DOCK9 RB1CC1 PRAMEF1 PRAMEF13 MDN1 PRAMEF14 FGD1 MGA NIN | 5.83e-06 | 363 | 155 | 10 | 14691545 |
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | 5.99e-06 | 153 | 155 | 7 | 26365490 | |
| Pubmed | Polo-like kinase 1 regulates Nlp, a centrosome protein involved in microtubule nucleation. | 6.24e-06 | 58 | 155 | 5 | 12852856 | |
| Pubmed | 6.81e-06 | 156 | 155 | 7 | 22952844 | ||
| Pubmed | SHANK1 RANBP2 SHROOM3 MYH10 CLIP2 CENPF ERC1 VIRMA MDN1 ANAPC1 N4BP2 NISCH SYNE2 WDFY3 MGA PCNT | 6.94e-06 | 963 | 155 | 16 | 28671696 | |
| Pubmed | 8.02e-06 | 61 | 155 | 5 | 7790358 | ||
| Pubmed | 8.24e-06 | 225 | 155 | 8 | 12168954 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | SHROOM3 DOCK9 INTS1 LMTK2 GEMIN5 CEP192 LYST MDN1 NISCH CHD5 RRP12 ULK4 ZFYVE26 LRRC14 PRKDC WDFY3 PCNT | 9.64e-06 | 1105 | 155 | 17 | 35748872 |
| Pubmed | 9.67e-06 | 230 | 155 | 8 | 35449600 | ||
| Pubmed | 1.02e-05 | 10 | 155 | 3 | 25220058 | ||
| Pubmed | SHROOM3 EFCAB6 MYO1C CNTRL PSMD7 CEP192 FMNL2 TRIP12 RIF1 PRKDC WDR41 MGA NOL8 ZC3HAV1 | 1.09e-05 | 777 | 155 | 14 | 35844135 | |
| Pubmed | 1.10e-05 | 234 | 155 | 8 | 36243803 | ||
| Pubmed | 1.18e-05 | 66 | 155 | 5 | 12221128 | ||
| Pubmed | Functional specialization of beta-arrestin interactions revealed by proteomic analysis. | 1.36e-05 | 317 | 155 | 9 | 17620599 | |
| Pubmed | CLIP2 CEP290 MRPS27 FMNL2 N4BP2 TLR1 CEP152 LRRC14 MGA EXOC4 TANGO6 | 1.44e-05 | 493 | 155 | 11 | 15368895 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | RANBP2 CENPF ANXA2 CEP290 INTS1 NOL11 RB1CC1 SPECC1 TRIP12 RIF1 MDN1 RRP12 SYNE2 PRKDC MGA PCNT | 1.48e-05 | 1024 | 155 | 16 | 24711643 |
| Pubmed | MYH10 ERC1 DOCK9 HEATR5A CEP192 VIRMA NISCH RRP12 VPS13B PCNT | 1.57e-05 | 407 | 155 | 10 | 12693553 | |
| Pubmed | Tumor suppressor BAP1 nuclear import is governed by transportin-1. | RANBP2 MYH10 ERC1 ANXA2 COPB2 STK38 MRPS27 GEMIN5 PSMD7 COPS3 MDN1 SARS1 NISCH RRP12 PRKDC EIF3H ZC3HAV1 | 1.59e-05 | 1149 | 155 | 17 | 35446349 |
| Pubmed | Regulation of epidermal differentiation through KDF1-mediated deubiquitination of IKKα. | 1.86e-05 | 182 | 155 | 7 | 32239614 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 1.96e-05 | 332 | 155 | 9 | 32786267 | |
| Pubmed | An immunocompromised murine model of chronic Bartonella infection. | 1.97e-05 | 2 | 155 | 2 | 20395436 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 19536308 | ||
| Pubmed | Two novel arrangements of the human fetal globin genes: G gamma-G gamma and A gamma-A gamma. | 1.97e-05 | 2 | 155 | 2 | 6091051 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 21321362 | ||
| Pubmed | Annexin A2 modulates radiation-sensitive transcriptional programming and cell fate. | 1.97e-05 | 2 | 155 | 2 | 23148505 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 29932071 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 11956314 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 11172039 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 38290972 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 3013423 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 35064931 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 2413469 | ||
| Pubmed | Complex Roles of Annexin A2 in Host Blood-Brain Barrier Invasion by Cryptococcus neoformans. | 1.97e-05 | 2 | 155 | 2 | 28130864 | |
| Pubmed | Nonspecific immune responses and mechanisms of resistance to Eimeria papillata infections in mice. | 1.97e-05 | 2 | 155 | 2 | 9234770 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 17392156 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 17549680 | ||
| Pubmed | Two mouse early embryonic beta-globin gene sequences. Evolution of the nonadult beta-globins. | 1.97e-05 | 2 | 155 | 2 | 6323438 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 39384746 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 5554303 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 20826156 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 8911578 | ||
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 8140728 | ||
| Pubmed | Prohibitin/annexin 2 interaction regulates fatty acid transport in adipose tissue. | 1.97e-05 | 2 | 155 | 2 | 27468426 | |
| Pubmed | 1.97e-05 | 2 | 155 | 2 | 24435807 | ||
| Pubmed | Spontaneous and experimental infections in scid and scid/beige mice. | 1.97e-05 | 2 | 155 | 2 | 8320959 | |
| Pubmed | Homocysteine inhibits neoangiogenesis in mice through blockade of annexin A2-dependent fibrinolysis. | 1.97e-05 | 2 | 155 | 2 | 19841537 | |
| Interaction | YWHAG interactions | UAP1 SHROOM3 MYH10 AFTPH ERC1 DOCK9 KLC2 LMTK2 CEP192 RB1CC1 SPECC1 TRIP12 VIRMA LYST LGALS8 ARRB1 MDN1 CEP78 PIK3C2A PIK3C3 N4BP2 TNFSF13B SYNE2 TET1 RBM15B PRKDC PRLR PPP6R3 EXOC4 ZC3HAV1 | 6.89e-09 | 1248 | 148 | 30 | int:YWHAG |
| Interaction | YWHAH interactions | UAP1 SHROOM3 AFTPH ERC1 DOCK9 CNTRL CEP290 KLC2 LMTK2 PSMD7 CEP192 RB1CC1 SPECC1 TRIP12 VIRMA LYST ARRB1 PIK3C2A PIK3C3 SYNE2 TET1 RBM15B CEP152 EXOC4 PCNT ZC3HAV1 NIN | 3.01e-08 | 1102 | 148 | 27 | int:YWHAH |
| Interaction | CNTRL interactions | ERC1 CNTRL POLR2C COPB2 PSMD7 CEP192 VIRMA CEP152 EXOC4 PCNT NIN | 1.91e-07 | 193 | 148 | 11 | int:CNTRL |
| Interaction | SIRT7 interactions | RANBP2 MYH10 MYO1C CENPF COPB2 INTS1 NOL11 GEMIN5 NOL10 TRIP12 VIRMA RIF1 MDN1 ANAPC1 RRP12 SYNE2 PRKDC PPP6R3 PCNT ZC3HAV1 | 5.50e-07 | 744 | 148 | 20 | int:SIRT7 |
| Interaction | HECTD1 interactions | SHROOM3 MYH10 CENPF ANXA2 COPB2 MRPS27 NOL11 NOL10 TRIP12 VIRMA RIF1 MDN1 CEP78 PIK3C3 RRP12 RBM15B PRKDC UTP3 EIF3H NOL8 EXOC4 ZC3HAV1 NIN | 8.29e-07 | 984 | 148 | 23 | int:HECTD1 |
| Interaction | SYNE3 interactions | RANBP2 SHROOM3 STBD1 ERC1 LAMB1 CEP192 MIA2 PIK3C2A ANAPC1 N4BP2 SYNE2 CEP152 PCNT ZC3HAV1 NIN | 1.00e-06 | 444 | 148 | 15 | int:SYNE3 |
| Interaction | ATG16L1 interactions | RANBP2 SHROOM3 ERC1 CNTRL POLR2C LMTK2 GEMIN5 CEP192 RABGAP1 RB1CC1 SPECC1 TRIP12 CEP78 PIK3C2A PIK3C3 N4BP2 HPS4 RRP12 RBM15B MTR CEP152 WDFY3 EIF3H EXOC4 ZC3HAV1 | 1.17e-06 | 1161 | 148 | 25 | int:ATG16L1 |
| Interaction | ANAPC2 interactions | ERC1 KLC2 CEP192 PIK3C2A ANAPC1 N4BP2 MTR CEP152 PRKDC EXOC4 PCNT | 1.29e-06 | 234 | 148 | 11 | int:ANAPC2 |
| Interaction | KDM1A interactions | RANBP2 ZNF609 CENPF ERC1 GEMIN5 COPS3 RABGAP1 RB1CC1 VIRMA TLE5 ANAPC1 NFE2L2 N4BP2 TET1 CEP152 NOSTRIN MGA PPP6R3 EXOC4 TANGO6 PCNT NIN | 1.47e-06 | 941 | 148 | 22 | int:KDM1A |
| Interaction | OFD1 interactions | ERC1 CNTRL POLR2C CEP290 KLC2 PSMD7 CEP192 RB1CC1 VIRMA CEP152 EXOC4 PCNT NIN | 1.77e-06 | 347 | 148 | 13 | int:OFD1 |
| Interaction | CIT interactions | RANBP2 AMPD3 MYH10 AFTPH MYO1C CENPF ERC1 ANXA2 ANXA2P2 DDX60 COPB2 INTS1 MRPS27 NOL11 CDK11A HEATR5A NOL10 SPECC1 TRIP12 VIRMA RIF1 RRP12 SYNE2 PRKDC UTP3 EIF3H ZC3HAV1 NIN | 2.09e-06 | 1450 | 148 | 28 | int:CIT |
| Interaction | NANOG interactions | RANBP2 ZNF609 CENPF ERC1 INTS1 PSMD7 RB1CC1 SPECC1 TRIP12 VIRMA RIF1 MDN1 RRP12 TET1 MGA | 2.69e-06 | 481 | 148 | 15 | int:NANOG |
| Interaction | DNAJC7 interactions | ANXA2 DDX60 NCAPG2 MKNK1 MDN1 SARS1 EML5 PIK3C2A MTR PRKDC WDR41 VPS13B TANGO6 PCNT | 3.14e-06 | 425 | 148 | 14 | int:DNAJC7 |
| Interaction | YWHAZ interactions | UAP1 SHROOM3 MYH10 CLIP2 NELFA ERC1 ANXA2 DOCK9 STK38 KLC2 NOL11 CEP192 RB1CC1 SPECC1 TRIP12 VIRMA LYST ARRB1 PIK3C2A PIK3C3 NISCH SYNE2 WDFY3 PRLR PCNT NIN | 3.55e-06 | 1319 | 148 | 26 | int:YWHAZ |
| Interaction | MAU2 interactions | 7.45e-06 | 136 | 148 | 8 | int:MAU2 | |
| Interaction | CPAP interactions | 8.18e-06 | 182 | 148 | 9 | int:CPAP | |
| Interaction | ATG5 interactions | MYH10 DOCK9 MRPS27 LAMB1 GEMIN5 RABGAP1 RB1CC1 PIK3C2A PIK3C3 WDFY3 EXOC4 ZC3HAV1 | 9.24e-06 | 344 | 148 | 12 | int:ATG5 |
| Interaction | FBXO22 interactions | CENPF DOCK9 PCDHB9 MRPS27 KLC2 CDK11A PSMD7 VPS36 COPS3 TRIP12 MIDN MDN1 SARS1 RRP12 UTP3 | 1.08e-05 | 540 | 148 | 15 | int:FBXO22 |
| Interaction | NIN interactions | ERC1 ANXA2 CNTRL CEP290 CEP192 VIRMA STXBP3 CEP152 MGA EXOC4 PCNT NIN | 1.41e-05 | 359 | 148 | 12 | int:NIN |
| Interaction | CEP350 interactions | 1.46e-05 | 149 | 148 | 8 | int:CEP350 | |
| Interaction | CLEC16A interactions | RANBP2 MYO1C POLR2C COPB2 PSMD7 VIRMA RIF1 MDN1 SARS1 ANAPC1 RRP12 MTR WDR41 UTP3 PPP6R3 ZC3HAV1 | 1.61e-05 | 629 | 148 | 16 | int:CLEC16A |
| Interaction | RCOR1 interactions | RANBP2 MYH10 CENPF ERC1 GEMIN5 RABGAP1 RB1CC1 VIRMA ANAPC1 TET1 MGA PPP6R3 EXOC4 TANGO6 | 1.73e-05 | 494 | 148 | 14 | int:RCOR1 |
| Interaction | APEX1 interactions | MYO1C CLIP2 CENPF ERC1 DOCK9 CEP290 KLC2 NOL11 CDK11A NOL10 COPS3 TRIP12 VIRMA ADAMTS10 RIF1 ARRB1 NFE2L2 RRP12 PRKDC UTP3 MGA MSLN NOL8 ZC3HAV1 | 1.81e-05 | 1271 | 148 | 24 | int:APEX1 |
| Interaction | LRRC31 interactions | 2.12e-05 | 205 | 148 | 9 | int:LRRC31 | |
| Interaction | LAMTOR1 interactions | MYO1C KLC2 LMTK2 CEP192 RABGAP1 SPECC1 FMNL2 PIK3C2A PIK3C3 N4BP2 NISCH MTR ZFYVE26 WDR41 VPS13B EXOC4 ZC3HAV1 | 2.33e-05 | 722 | 148 | 17 | int:LAMTOR1 |
| Interaction | PFN1 interactions | RANBP2 ERC1 ANXA2 CEP192 RABGAP1 FMNL2 VIRMA PIK3C2A N4BP2 CHD5 SYNE2 MTR CEP152 PCNT | 2.40e-05 | 509 | 148 | 14 | int:PFN1 |
| Interaction | SMG7 interactions | ZNF609 CDK11A PSMD7 RABGAP1 TLE5 CHD5 RRP12 TET1 CEP152 ZC3HAV1 NIN | 2.45e-05 | 319 | 148 | 11 | int:SMG7 |
| Interaction | TNFSF13B interactions | 2.82e-05 | 119 | 148 | 7 | int:TNFSF13B | |
| Interaction | CTTN interactions | RANBP2 MYO1C RB1CC1 SPECC1 FMNL2 NCAPG2 ARRB1 SARS1 RBM15B FGD1 MYH15 EIF3H NIN | 2.86e-05 | 450 | 148 | 13 | int:CTTN |
| Interaction | RAB9A interactions | STBD1 CNTRL LMTK2 RABGAP1 SPECC1 VIRMA MANSC1 PIK3C3 NISCH RRP12 SYNE2 ZFYVE26 WDR41 VPS13B ZC3HAV1 | 3.34e-05 | 595 | 148 | 15 | int:RAB9A |
| Interaction | NUP62 interactions | 3.48e-05 | 273 | 148 | 10 | int:NUP62 | |
| Interaction | CCDC138 interactions | 3.49e-05 | 123 | 148 | 7 | int:CCDC138 | |
| Interaction | RAB11A interactions | MYH10 STBD1 AFTPH ANXA2 STK38 LMTK2 HEATR5A RABGAP1 SPECC1 VIRMA NISCH RRP12 SYNE2 WDR41 WDFY3 VPS13B EXOC4 ZC3HAV1 | 3.90e-05 | 830 | 148 | 18 | int:RAB11A |
| Interaction | YWHAE interactions | UAP1 SHROOM3 MYH10 STBD1 ERC1 DOCK9 KLC2 CDK11A RB1CC1 SPECC1 TRIP12 VIRMA LYST LGALS8 MIDN ARRB1 STXBP3 PIK3C2A NISCH TET1 MGA EXOC4 NIN | 4.46e-05 | 1256 | 148 | 23 | int:YWHAE |
| Interaction | CCDC14 interactions | 4.73e-05 | 129 | 148 | 7 | int:CCDC14 | |
| Interaction | PHF21A interactions | RANBP2 CENPF ERC1 RABGAP1 RB1CC1 ANAPC1 TET1 MGA EXOC4 TANGO6 PCNT | 4.75e-05 | 343 | 148 | 11 | int:PHF21A |
| Interaction | ULK4 interactions | 4.99e-05 | 28 | 148 | 4 | int:ULK4 | |
| Interaction | POLR1E interactions | RANBP2 POLR2C CDK11A NOL10 ARRB1 MDN1 RRP12 TET1 UTP3 MGA NOL8 | 5.69e-05 | 350 | 148 | 11 | int:POLR1E |
| Interaction | TRIM52 interactions | 5.74e-05 | 133 | 148 | 7 | int:TRIM52 | |
| Interaction | MIB1 interactions | 6.68e-05 | 295 | 148 | 10 | int:MIB1 | |
| Interaction | POLR1G interactions | POLR2C NOL11 CDK11A PSMD7 NOL10 TRIP12 NCAPG2 ARRB1 MDN1 RRP12 UTP3 MGA NOL8 | 6.70e-05 | 489 | 148 | 13 | int:POLR1G |
| Interaction | CEP43 interactions | 8.24e-05 | 190 | 148 | 8 | int:CEP43 | |
| Interaction | PCM1 interactions | ERC1 CNTRL CEP290 NOL11 CEP192 CCDC92 RB1CC1 VIRMA CEP152 EXOC4 PCNT NIN | 8.91e-05 | 434 | 148 | 12 | int:PCM1 |
| Interaction | DOT1L interactions | RANBP2 MYH10 MYO1C CLIP2 NOL11 NOL10 TRIP12 VIRMA RIF1 MDN1 RRP12 RBM15B PRKDC UTP3 NOL8 ZC3HAV1 NIN | 9.25e-05 | 807 | 148 | 17 | int:DOT1L |
| Interaction | SEPTIN10 interactions | 9.49e-05 | 144 | 148 | 7 | int:SEPTIN10 | |
| Interaction | CEP85L interactions | 9.68e-05 | 33 | 148 | 4 | int:CEP85L | |
| Interaction | AP2B1 interactions | AFTPH CEP192 FMNL2 VIRMA MIDN ARRB1 PIK3C2A N4BP2 CEP152 PPP6R3 PCNT | 1.00e-04 | 373 | 148 | 11 | int:AP2B1 |
| Interaction | LATS1 interactions | MYO1C CEP290 CEP192 VIRMA RIF1 MDN1 ANAPC1 CEP152 MGA PPP6R3 PCNT NIN | 1.01e-04 | 440 | 148 | 12 | int:LATS1 |
| Interaction | PIPSL interactions | 1.05e-04 | 252 | 148 | 9 | int:PIPSL | |
| Interaction | CEP131 interactions | 1.18e-04 | 200 | 148 | 8 | int:CEP131 | |
| Interaction | FGF3 interactions | 1.24e-04 | 66 | 148 | 5 | int:FGF3 | |
| Interaction | MED4 interactions | ERC1 CNTRL POLR2C CEP290 GEMIN5 CDK11A PSMD7 TLE5 CEP152 EXOC4 PCNT NIN | 1.25e-04 | 450 | 148 | 12 | int:MED4 |
| Interaction | WDR76 interactions | RANBP2 MYH10 ANXA2 INTS1 LAMB1 TRIP12 MDN1 ANAPC1 RRP12 PRKDC ZC3HAV1 | 1.27e-04 | 383 | 148 | 11 | int:WDR76 |
| Interaction | TRIM33 interactions | RANBP2 MYH10 ERC1 ANXA2 ANXA2P2 POLR2C KLC2 VIRMA CEP78 ANAPC1 PRKDC NIN | 1.33e-04 | 453 | 148 | 12 | int:TRIM33 |
| Interaction | LGR4 interactions | 1.41e-04 | 262 | 148 | 9 | int:LGR4 | |
| Interaction | PLK4 interactions | 1.44e-04 | 154 | 148 | 7 | int:PLK4 | |
| Interaction | CTAGE4 interactions | 1.60e-04 | 3 | 148 | 2 | int:CTAGE4 | |
| Interaction | OPN1MW2 interactions | 1.60e-04 | 3 | 148 | 2 | int:OPN1MW2 | |
| Interaction | SASS6 interactions | 1.76e-04 | 159 | 148 | 7 | int:SASS6 | |
| Interaction | HDAC1 interactions | RANBP2 MYH10 ZNF609 EFCAB6 CENPF ERC1 GEMIN5 COPS3 RABGAP1 RB1CC1 VIRMA NFE2L2 CHD5 SYNE2 TET1 MGA PPP6R3 EXOC4 TANGO6 PCNT | 1.78e-04 | 1108 | 148 | 20 | int:HDAC1 |
| Interaction | CYLD interactions | MYH10 ZNF609 ERC1 ANXA2 COPB2 STK38 GEMIN5 CEP192 VIRMA PIK3C3 NFE2L2 PRKDC EIF3H MGA EXOC4 ZC3HAV1 NIN | 2.21e-04 | 868 | 148 | 17 | int:CYLD |
| Interaction | ATG7 interactions | NOL10 VPS36 RB1CC1 NCAPG2 SARS1 PIK3C2A PIK3C3 NFE2L2 GSDMD RRP12 TANGO6 | 2.28e-04 | 410 | 148 | 11 | int:ATG7 |
| Interaction | CEP162 interactions | 2.46e-04 | 168 | 148 | 7 | int:CEP162 | |
| Interaction | ARHGAP21 interactions | 2.48e-04 | 223 | 148 | 8 | int:ARHGAP21 | |
| Interaction | CCDC6 interactions | 2.70e-04 | 286 | 148 | 9 | int:CCDC6 | |
| Interaction | KRT18 interactions | ERC1 CEP290 CEP192 RB1CC1 VIRMA N4BP2 CEP152 EIF3H TANGO6 PCNT NIN | 2.75e-04 | 419 | 148 | 11 | int:KRT18 |
| Interaction | SOX2 interactions | RANBP2 ZNF609 MYO1C ANXA2 POLR2C INTS1 MRPS27 NOL11 CDK11A PSMD7 COPS3 TRIP12 SERPINA12 MDN1 TLE5 ANAPC1 RRP12 UTP3 ANXA9 QDPR LRRC17 PCNT NIN | 2.82e-04 | 1422 | 148 | 23 | int:SOX2 |
| Interaction | SAMD4B interactions | 2.85e-04 | 122 | 148 | 6 | int:SAMD4B | |
| Interaction | PRC1 interactions | RANBP2 MYH10 CENPF NELFA ANXA2 ANXA2P2 KLC2 NOL11 PSMD7 NOL10 SPECC1 VIRMA ANAPC1 CHD5 RRP12 PRKDC UTP3 ZC3HAV1 | 2.86e-04 | 973 | 148 | 18 | int:PRC1 |
| Interaction | APOA5 interactions | 2.92e-04 | 18 | 148 | 3 | int:APOA5 | |
| Interaction | PALLD interactions | 2.97e-04 | 123 | 148 | 6 | int:PALLD | |
| Interaction | WRAP73 interactions | 2.97e-04 | 123 | 148 | 6 | int:WRAP73 | |
| Interaction | PHF8 interactions | 3.05e-04 | 174 | 148 | 7 | int:PHF8 | |
| Interaction | DCTN2 interactions | 3.08e-04 | 356 | 148 | 10 | int:DCTN2 | |
| Interaction | TTC3 interactions | 3.11e-04 | 124 | 148 | 6 | int:TTC3 | |
| Interaction | RABGAP1 interactions | 3.24e-04 | 125 | 148 | 6 | int:RABGAP1 | |
| Interaction | DISC1 interactions | ANXA2 CEP290 RABGAP1 CCDC92 CCDC141 VIRMA N4BP2 EIF3H PPP6R3 EXOC4 PCNT | 3.36e-04 | 429 | 148 | 11 | int:DISC1 |
| Interaction | H3C1 interactions | MYH10 CEP290 INTS1 MRPS27 TRIP12 VIRMA RIF1 SARS1 ANAPC1 NFE2L2 DAW1 RRP12 MYH15 PRKDC UTP3 MGA DNAH9 | 3.40e-04 | 901 | 148 | 17 | int:H3C1 |
| Interaction | OBSL1 interactions | RANBP2 SHROOM3 CENPF ANXA2 NOL11 LAMB1 PSMD7 NOL10 TRIP12 RIF1 MDN1 RRP12 SYNE2 PRKDC UTP3 MGA PCNT | 3.44e-04 | 902 | 148 | 17 | int:OBSL1 |
| Interaction | HAUS8 interactions | 3.53e-04 | 127 | 148 | 6 | int:HAUS8 | |
| Interaction | CEP152 interactions | 3.62e-04 | 179 | 148 | 7 | int:CEP152 | |
| Interaction | GJA1 interactions | STBD1 STK38 LMTK2 HEATR5A RABGAP1 SPECC1 MIDN PIK3C3 NISCH SYNE2 VPS13B EXOC4 ZC3HAV1 | 3.76e-04 | 583 | 148 | 13 | int:GJA1 |
| Interaction | GRK5 interactions | 4.00e-04 | 182 | 148 | 7 | int:GRK5 | |
| Interaction | SUSD5 interactions | 4.04e-04 | 20 | 148 | 3 | int:SUSD5 | |
| Interaction | HOOK1 interactions | 4.05e-04 | 240 | 148 | 8 | int:HOOK1 | |
| Interaction | CXADR interactions | STBD1 COPB2 FMNL2 MIDN NISCH SYNE2 FGD1 WDR41 VPS13B ZC3HAV1 | 4.08e-04 | 369 | 148 | 10 | int:CXADR |
| Interaction | GOLGA1 interactions | 4.14e-04 | 183 | 148 | 7 | int:GOLGA1 | |
| Interaction | PCNT interactions | 4.17e-04 | 241 | 148 | 8 | int:PCNT | |
| Interaction | ARRB1 interactions | 4.22e-04 | 304 | 148 | 9 | int:ARRB1 | |
| Interaction | STIP1 interactions | RANBP2 MYH10 DDX60 POLR2C COPB2 NOL11 GEMIN5 PSMD7 VIRMA LRRC9 RIF1 MDN1 SARS1 PRKDC EIF3H PPP6R3 EXOC4 ZC3HAV1 | 4.27e-04 | 1006 | 148 | 18 | int:STIP1 |
| Interaction | SUMO2 interactions | RANBP2 COPB2 GEMIN5 TRIP12 RIF1 MYG1 MDN1 SARS1 CEP78 ANAPC1 NFE2L2 PRKDC SENP5 | 4.27e-04 | 591 | 148 | 13 | int:SUMO2 |
| Interaction | SLFN11 interactions | RANBP2 MYH10 MYO1C CENPF ANXA2 RB1CC1 TRIP12 RIF1 RRP12 EIF3H | 4.73e-04 | 376 | 148 | 10 | int:SLFN11 |
| Interaction | MTNR1B interactions | 4.89e-04 | 135 | 148 | 6 | int:MTNR1B | |
| Interaction | AURKB interactions | RANBP2 MYH10 MYO1C ANXA2 CNTRL MRPS27 PSMD7 HEATR5A CEP192 RIF1 RRP12 CEP152 PRKDC PPP6R3 ZC3HAV1 | 4.92e-04 | 761 | 148 | 15 | int:AURKB |
| Interaction | AMOT interactions | 5.09e-04 | 312 | 148 | 9 | int:AMOT | |
| Interaction | DHX40 interactions | 5.17e-04 | 249 | 148 | 8 | int:DHX40 | |
| Interaction | PSMD14 interactions | SHROOM3 CNTRL STK38 PSMD7 COPS3 CCDC92 VIRMA MIDN STXBP3 SYNE2 NOSTRIN PCNT | 5.26e-04 | 527 | 148 | 12 | int:PSMD14 |
| Interaction | CTAGE15 interactions | 5.28e-04 | 5 | 148 | 2 | int:CTAGE15 | |
| Interaction | BICD1 interactions | 5.31e-04 | 250 | 148 | 8 | int:BICD1 | |
| Interaction | FEZ1 interactions | 5.31e-04 | 90 | 148 | 5 | int:FEZ1 | |
| Cytoband | 8q11 | 1.68e-04 | 6 | 155 | 2 | 8q11 | |
| GeneFamily | WD repeat domain containing | 7.16e-05 | 262 | 95 | 8 | 362 | |
| GeneFamily | Classical arrestins | 1.63e-04 | 4 | 95 | 2 | 1312 | |
| GeneFamily | PRAME family | 2.63e-04 | 24 | 95 | 3 | 686 | |
| GeneFamily | Zinc fingers FYVE-type|Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors | 5.68e-04 | 31 | 95 | 3 | 81 | |
| GeneFamily | Phosphatidylinositol 3-kinase subunits | 7.49e-04 | 8 | 95 | 2 | 831 | |
| GeneFamily | WD repeat domain containing|BEACH domain containing | 9.60e-04 | 9 | 95 | 2 | 1230 | |
| GeneFamily | CD molecules|Toll like receptors | 1.20e-03 | 10 | 95 | 2 | 948 | |
| GeneFamily | Hemoglobin subunits | 1.20e-03 | 10 | 95 | 2 | 940 | |
| GeneFamily | Annexins|Endogenous ligands | 2.05e-03 | 13 | 95 | 2 | 404 | |
| GeneFamily | Myosin heavy chains | 2.74e-03 | 15 | 95 | 2 | 1098 | |
| GeneFamily | CTAGE family | 2.74e-03 | 15 | 95 | 2 | 907 | |
| Coexpression | GSE14699_NAIVE_VS_ACT_CD8_TCELL_DN | 1.05e-06 | 175 | 155 | 9 | M2940 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | RANBP2 CENPF ERC1 DOCK9 RABGAP1 RB1CC1 TRIP12 RIF1 MDN1 MIA2 STXBP3 PIK3C2A PIK3C3 SYNE2 MTR WDFY3 VPS13B PCNT | 3.36e-06 | 856 | 155 | 18 | M4500 |
| Coexpression | GSE37301_MULTIPOTENT_PROGENITOR_VS_LYMPHOID_PRIMED_MPP_UP | 4.74e-06 | 158 | 155 | 8 | M8888 | |
| Coexpression | GSE25146_UNSTIM_VS_HELIOBACTER_PYLORI_LPS_STIM_AGS_CELL_DN | 6.83e-06 | 166 | 155 | 8 | M8129 | |
| Coexpression | GSE13946_CTRL_VS_DSS_COLITIS_GD_TCELL_FROM_COLON_DN | 8.13e-06 | 170 | 155 | 8 | M2942 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_TTD_DN | 1.08e-05 | 84 | 155 | 6 | M13008 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_XPCS_DN | 1.15e-05 | 85 | 155 | 6 | M10575 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | 2.54e-05 | 199 | 155 | 8 | M5893 | |
| Coexpression | GSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_UP | 5.23e-05 | 162 | 155 | 7 | M7005 | |
| Coexpression | GSE15330_LYMPHOID_MULTIPOTENT_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_IKAROS_KO_UP | 6.10e-05 | 166 | 155 | 7 | M7009 | |
| Coexpression | GSE37534_GW1929_VS_ROSIGLITAZONE_TREATED_CD4_TCELL_PPARG1_FOXP3_TRANSDUCED_UP | 6.10e-05 | 166 | 155 | 7 | M8987 | |
| Coexpression | GSE15330_HSC_VS_MEGAKARYOCYTE_ERYTHROID_PROGENITOR_DN | 6.58e-05 | 168 | 155 | 7 | M7007 | |
| Coexpression | LI_PBMC_MENACTRA_AGE_18_45YO_CORRELATED_WITH_ANTI_DT_ANTIBODY_3DY_POSITIVE | 9.11e-05 | 40 | 155 | 4 | M41037 | |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_k-means-cluster#4_top-relative-expression-ranked_500 | 7.21e-06 | 101 | 149 | 7 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_k4_500 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ testes_emap-6710_top-relative-expression-ranked_500 | MORC1 MYO1C LAMB1 PSMD7 TRIP12 RIF1 TLE5 NISCH MTR MGA HBG2 PRLR | 3.44e-05 | 411 | 149 | 12 | gudmap_developingGonad_e14.5_ testes_500 |
| CoexpressionAtlas | dev gonad_e12.5_M_GermCellTestis_Oct_k-means-cluster#4_top-relative-expression-ranked_500 | 6.31e-05 | 97 | 149 | 6 | gudmap_dev gonad_e12.5_M_GermCellTestis_Oct_k4_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_top-relative-expression-ranked_1000 | MORC1 MYO1C NELFA LAMB1 GEMIN5 PSMD7 TRIP12 ADAMTS10 RIF1 TLE5 NISCH RRP12 SYNE2 MTR MGA PRLR LRRC17 | 6.40e-05 | 819 | 149 | 17 | gudmap_developingGonad_e16.5_testes_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Hind Brain Neural Epithelium_top-relative-expression-ranked_2500_k-means-cluster#3 | RANBP2 CENPF CEP290 HEATR5A CEP192 RIF1 MIA2 EML5 N4BP2 PRKDC UTP3 NOL8 PCNT | 9.95e-05 | 532 | 149 | 13 | Facebase_RNAseq_e8.5_Hind Brain Neural Epithelium_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e16.5_testes_emap-8444_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.16e-04 | 68 | 149 | 5 | gudmap_developingGonad_e16.5_testes_1000_k1 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_ovary_emap-12283_top-relative-expression-ranked_1000 | MORC1 DOCK9 CEP290 PCDHB9 GEMIN5 RB1CC1 CCDC141 EGFL6 RIF1 STXBP3 NISCH SYNE2 WDFY3 MGA LRRC17 ZC3HAV1 | 1.18e-04 | 778 | 149 | 16 | gudmap_developingGonad_e18.5_ovary_1000 |
| CoexpressionAtlas | FacebaseRNAseq_e8.5_Floor Plate_top-relative-expression-ranked_2500_k-means-cluster#1 | RANBP2 EFCAB6 CENPF CEP290 HEATR5A CEP192 RIF1 PIK3C2A TET1 PRKDC UTP3 NOL8 | 1.21e-04 | 469 | 149 | 12 | Facebase_RNAseq_e8.5_Floor Plate_2500_K1 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_top-relative-expression-ranked_500 | MORC1 PSMD7 RIF1 NISCH SYNE2 TET1 MTR WDFY3 MGA HBG2 ZC3HAV1 | 1.33e-04 | 403 | 149 | 11 | gudmap_developingGonad_e12.5_epididymis_500 |
| CoexpressionAtlas | dev gonad_e12.5_F_GermCellOvary_Oct_top-relative-expression-ranked_500 | MORC1 CENPF CEP192 NCAPG2 RIF1 MDN1 TET1 MTR FGD1 PRKDC NOL8 | 1.42e-04 | 406 | 149 | 11 | gudmap_dev gonad_e12.5_F_GermCellOvary_Oct_500 |
| CoexpressionAtlas | DevelopingGonad_e12.5_epididymis_emap-29139_k-means-cluster#3_top-relative-expression-ranked_500 | 1.54e-04 | 114 | 149 | 6 | gudmap_developingGonad_e12.5_epididymis_k3_500 | |
| CoexpressionAtlas | DevelopingGonad_e11.5_testes and mesonephros_emap-3226_k-means-cluster#4_top-relative-expression-ranked_1000 | 1.61e-04 | 164 | 149 | 7 | gudmap_developingGonad_e11.5_testes and mesonephros_k4_1000 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 3.83e-07 | 192 | 155 | 8 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 3.98e-07 | 193 | 155 | 8 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 3.98e-07 | 193 | 155 | 8 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.84e-06 | 176 | 155 | 7 | 76fdf211bce101e83a27d822cb399487bd107027 | |
| ToppCell | (04)_Pre-ciliated|World / shred by cell type and Timepoint | 4.87e-06 | 191 | 155 | 7 | 37cf121e6e80760c8519075b7845b9029958a988 | |
| ToppCell | facs-Bladder-nan-3m|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.77e-06 | 196 | 155 | 7 | 44f5b1b474399c9316729155f2ea95a82ca66e30 | |
| ToppCell | facs-Bladder-nan-3m-Epithelial|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.77e-06 | 196 | 155 | 7 | c0e90d964baa2eb4fbd18a52379ccec5d3bf59a8 | |
| ToppCell | (11)_FOXN4+-(2)_GFP_FOXI1|(11)_FOXN4+ / shred by cell type by condition | 6.17e-06 | 198 | 155 | 7 | 76d40b8c2f8399725b3a62ee2ae0896559cf91eb | |
| ToppCell | severe-Myeloid-Neutrophils_4|Myeloid / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 6.37e-06 | 199 | 155 | 7 | 50242666def13e5d4149c563ae000d6768f086f7 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 6.37e-06 | 199 | 155 | 7 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | mild-CD8+_T_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 6.59e-06 | 200 | 155 | 7 | c825320599a61a4c629d736f5c0fd6f1f405540a | |
| ToppCell | lung-Club_Cells|lung / shred on tissue and cell subclass | 2.39e-05 | 164 | 155 | 6 | b12cacd499b18b96120ca6d14646aebeaed41d10 | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-granulocyte|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.12e-05 | 172 | 155 | 6 | d354424c1f861b6607dfd63b9724f4c237b30275 | |
| ToppCell | droplet-Marrow-nan-3m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.44e-05 | 175 | 155 | 6 | cf53a15bfb37b6019e7052ffdf594a9ac040900e | |
| ToppCell | facs-Marrow-Granulocytes-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.66e-05 | 177 | 155 | 6 | 065bebd22031f143e90a407f952b444a3f8818c7 | |
| ToppCell | facs-Marrow-Granulocytes-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.66e-05 | 177 | 155 | 6 | eb304f20aab075bd17aa3aef819386c0e1a235bd | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-05 | 178 | 155 | 6 | 01dafd19de04eff459253eaa9a35debf8f3deedf | |
| ToppCell | droplet-Liver-Npc-18m-Lymphocytic-macrophage/monocyte|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.78e-05 | 178 | 155 | 6 | 09d2687e0d79f12e90af35fc1c0453d249cf2d19 | |
| ToppCell | 3'_v3-bone_marrow-Myeloid_Dendritic-DC2|bone_marrow / Manually curated celltypes from each tissue | 4.41e-05 | 183 | 155 | 6 | f482e4fe011fa450a475034b1e25587233855bdb | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.41e-05 | 183 | 155 | 6 | f2ef110bf29b1a8276ef216238363e542db262c1 | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 4.55e-05 | 184 | 155 | 6 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.12e-05 | 188 | 155 | 6 | aa46073e2940dc1d2020b2e259bf0fc06cb990ee | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-Neutrophil-Neu_1|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 5.12e-05 | 188 | 155 | 6 | 04814b78da936a51a497e23060d19ca0d619e250 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.28e-05 | 189 | 155 | 6 | 9ab77c6fcb573854da5922412f53d2168bda6b58 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 5.28e-05 | 189 | 155 | 6 | 5a9e2ca9a9ee2dc37ab9147a902115a9f1a80169 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.59e-05 | 191 | 155 | 6 | 36467322096bc766cd777dae3bfb4e65511e492c | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.59e-05 | 191 | 155 | 6 | 8a73d2df079566fca4cbb5cdb85721c2e87134c8 | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-alveolar_fibroblast|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.59e-05 | 191 | 155 | 6 | 94795daf05061baa3b72a1b01c9e940af86de044 | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-alveolar_fibroblast-alveolar_fibroblast_l49|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.59e-05 | 191 | 155 | 6 | c715bbdbbf1482aad45a50a16d5232fd35a9a0bb | |
| ToppCell | droplet-Lung-21m-Mesenchymal-fibroblast-alveolar_fibroblast|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.59e-05 | 191 | 155 | 6 | 243d83cbfcc4996ad087ec6386e559e0b8662004 | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.76e-05 | 192 | 155 | 6 | df56c3e3bb1aafc1126607f4426554c09c8c40cf | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-Alveolar_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.76e-05 | 192 | 155 | 6 | d22c1135867bcb9076435e2c6eb1cc1248990d0c | |
| ToppCell | droplet-Lung-nan-18m-Mesenchymal-fibroblast_of_lung|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.76e-05 | 192 | 155 | 6 | c09966f4d63a739a56db4df7e0e0ee9ecacd21ad | |
| ToppCell | droplet-Lung-18m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l49|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 5.76e-05 | 192 | 155 | 6 | 1b228f0929b505de82a39bf64c837887b0e56701 | |
| ToppCell | kidney_cells-Adult_normal_reference-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell_cycling-Cycling_Proximal_Tubule_Epithelial_Cell_S-high|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 6.10e-05 | 194 | 155 | 6 | 0e9830ad070c47acaa952400bf2a3ddbff664a2f | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.27e-05 | 195 | 155 | 6 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.27e-05 | 195 | 155 | 6 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 6.27e-05 | 195 | 155 | 6 | 6477e6e7be5bd8eb99119a12ae16334ccddecd43 | |
| ToppCell | Control-Neu_4|Control / 5 Neutrophil clusters in COVID-19 patients | 6.45e-05 | 196 | 155 | 6 | b8b7b54ca17a08fa775507bb22b1c7248ada8f40 | |
| ToppCell | 10x5'-Liver-Lymphocytic_NK-NK_CD16|Liver / Manually curated celltypes from each tissue | 6.45e-05 | 196 | 155 | 6 | e6d4853ccefbcd45a019cee595811f0474dcc036 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.64e-05 | 197 | 155 | 6 | 74a2c6cb8fcfe53dd9a2b36492a16c58f38e51c9 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_monocytic-monocyte|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.64e-05 | 197 | 155 | 6 | ec46aa307ce5774b4c0fcba64514f2d0cab3c4f9 | |
| ToppCell | 10x_3'_v3-thymus_(10x_3'_v3)-myeloid-myeloid_monocytic|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 6.64e-05 | 197 | 155 | 6 | b91016249b3585aa3536e96af18e4f1b1d2d5ce4 | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Monocytic|lymph-node_spleen / Manually curated celltypes from each tissue | 6.83e-05 | 198 | 155 | 6 | 2541f1095ed91e6789cb888cf39a208b8107726a | |
| ToppCell | 10x5'-lymph-node_spleen-Myeloid_Monocytic-Classical_monocytes|lymph-node_spleen / Manually curated celltypes from each tissue | 6.83e-05 | 198 | 155 | 6 | 934dacb67d71faa2f8732c39d7f8e64b0ee75396 | |
| ToppCell | (0)_NK_cells-(0)_NK_FCGR3Apos|(0)_NK_cells / Spleen cell shreds - cell class (v1) and cell subclass (v1) | 6.83e-05 | 198 | 155 | 6 | eba39656c6f699ab297b652ded8cb9727b49593c | |
| ToppCell | normal-na-Myeloid|normal / PBMC cell types (v2) per disease, treatment status, and sex | 6.83e-05 | 198 | 155 | 6 | fd8ab3de94c3dc551f28668317109656fc58e463 | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 6.83e-05 | 198 | 155 | 6 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Monocytic-Classical_monocytes|lymph-node_spleen / Manually curated celltypes from each tissue | 6.83e-05 | 198 | 155 | 6 | 187a04d498f0b355cb11c81172721698818082d6 | |
| ToppCell | 3'_v3-lymph-node_spleen-Myeloid_Monocytic|lymph-node_spleen / Manually curated celltypes from each tissue | 6.83e-05 | 198 | 155 | 6 | 065c8a9655d19f93dfdb453c78bbfe7d857caf3e | |
| ToppCell | mild-HLA-DR-_S100A+_Monocyte|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.02e-05 | 199 | 155 | 6 | d0d286eafe935f9b3aaba5b783e8911251121b4a | |
| ToppCell | (10)_Ciliated-(2)_GFP_FOXI1|(10)_Ciliated / shred by cell type by condition | 7.02e-05 | 199 | 155 | 6 | 61b1ed2db71b96157b92b7535d1955a4033098da | |
| ToppCell | ASK452-Mesenchymal-Fibroblast|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.02e-05 | 199 | 155 | 6 | 4d0bf2a4bd97e5a3bfe4570a201cc21bb9c4c1f6 | |
| ToppCell | (02)_MMP9/10+-(2)_GFP_FOXI1|(02)_MMP9/10+ / shred by cell type by condition | 7.02e-05 | 199 | 155 | 6 | 18a7f9ced4364f45b184bd529f32ef02c27779d3 | |
| ToppCell | ASK452-Mesenchymal|ASK452 / Donor, Lineage and Cell class of Lung cells from Dropseq | 7.02e-05 | 199 | 155 | 6 | 93e85e3731a9ece9aee3eb82c5dfdad331ee62d6 | |
| ToppCell | mild-CD4+_T_naive|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.02e-05 | 199 | 155 | 6 | 3e4baaf4ee23f257d821194468102c00a8ad2f21 | |
| ToppCell | COVID-19-COVID-19_Mild-Lymphocyte-T/NK-dn_T|COVID-19_Mild / Disease, condition lineage and cell class | 7.02e-05 | 199 | 155 | 6 | f307d4887b28cf60a591439e278fd668409cb104 | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 7.22e-05 | 200 | 155 | 6 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | Control-Control-Lymphocyte-T/NK-dn_T|Control / Disease, condition lineage and cell class | 7.22e-05 | 200 | 155 | 6 | 10882c59b7aaf8bd4b5c00aa4ddbb9f7ac5b2cf5 | |
| ToppCell | severe-Neutrophil|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 7.22e-05 | 200 | 155 | 6 | f9af7e77a8483ab4ae708b55514e64f5420fa0c1 | |
| ToppCell | severe-Myeloid-Neutrophils_4|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 7.22e-05 | 200 | 155 | 6 | b665f36dcf3c9d3981ee96f2973512f751612542 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW12-Mesenchymal-Unfolded_protein_responsible_cell|GW12 / Sample Type, Dataset, Time_group, and Cell type. | 7.22e-05 | 200 | 155 | 6 | 6b7314c425f6b40f1301dd39cc02b0436e96a2ec | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Macroglial-Astrocyte|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 7.22e-05 | 200 | 155 | 6 | 7205e742ad796d548761839d92a4794ee8f17629 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Macroglial|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 7.22e-05 | 200 | 155 | 6 | 25b573f4427ecafe050ca90bea459f1b25b451cf | |
| Drug | 3M-011 | 2.66e-06 | 15 | 155 | 4 | CID003322418 | |
| Drug | irinotecan | MYH10 CENPF ERC1 ANXA2 CEP290 STK38 CEP192 LGALS8 MDN1 ULK4 PRKDC UTP3 HBG1 PRLR VPS13B EXOC4 ZC3HAV1 | 6.41e-06 | 703 | 155 | 17 | ctd:C051890 |
| Drug | Moxonidine [75438-57-2]; Up 200; 16.6uM; MCF7; HT_HG-U133A | 8.57e-06 | 197 | 155 | 9 | 7343_UP | |
| Disease | FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 1 | 7.47e-05 | 3 | 148 | 2 | 141749 | |
| Disease | Seckel syndrome 1 | 7.47e-05 | 3 | 148 | 2 | C4551474 | |
| Disease | Hereditary persistence of fetal hemoglobin | 7.47e-05 | 3 | 148 | 2 | cv:C0019025 | |
| Disease | delta beta-thalassemia (is_implicated_in) | 7.47e-05 | 3 | 148 | 2 | DOID:0080773 (is_implicated_in) | |
| Disease | Chediak-Higashi syndrome (implicated_via_orthology) | 1.49e-04 | 4 | 148 | 2 | DOID:2935 (implicated_via_orthology) | |
| Disease | melancholic depression (implicated_via_orthology) | 1.49e-04 | 4 | 148 | 2 | DOID:1595 (implicated_via_orthology) | |
| Disease | FETAL HEMOGLOBIN QUANTITATIVE TRAIT LOCUS 1 | 1.49e-04 | 4 | 148 | 2 | C1841621 | |
| Disease | Seckel syndrome | 1.78e-04 | 22 | 148 | 3 | C0265202 | |
| Disease | IgA glomerulonephritis (is_implicated_in) | 4.55e-04 | 30 | 148 | 3 | DOID:2986 (is_implicated_in) | |
| Disease | xerostomia | 6.86e-04 | 8 | 148 | 2 | EFO_0009869 | |
| Disease | creatinine measurement, chronic kidney disease | 7.19e-04 | 35 | 148 | 3 | EFO_0003884, EFO_0004518 | |
| Disease | Malignant neoplasm of breast | CENPF ARHGEF38 RB1CC1 RIF1 MIA2 DAW1 N4BP2 NISCH CHD5 SYNE2 MTR ZFYVE26 DNAH9 VPS13B | 1.05e-03 | 1074 | 148 | 14 | C0006142 |
| Disease | Prostatic Neoplasms | 1.14e-03 | 616 | 148 | 10 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 1.14e-03 | 616 | 148 | 10 | C0376358 | |
| Disease | autistic disorder (is_implicated_in) | 1.23e-03 | 42 | 148 | 3 | DOID:12849 (is_implicated_in) | |
| Disease | quality of life during menstruation measurement, dysmenorrheic pain measurement | 1.33e-03 | 11 | 148 | 2 | EFO_0007889, EFO_0009366 | |
| Disease | left ventricular systolic function measurement | 1.41e-03 | 44 | 148 | 3 | EFO_0008206 | |
| Disease | Gastrointestinal Diseases | 1.60e-03 | 12 | 148 | 2 | C0017178 | |
| Disease | Functional Gastrointestinal Disorders | 1.60e-03 | 12 | 148 | 2 | C0559031 | |
| Disease | Cholera Infantum | 1.60e-03 | 12 | 148 | 2 | C1565321 | |
| Disease | Schizophrenia | SHANK1 ABCA1 RB1CC1 EML5 PIK3C3 HPS4 TET1 EDEM2 TPH2 MTR ULK4 PCNT | 1.70e-03 | 883 | 148 | 12 | C0036341 |
| Disease | Psychotic Disorders | 1.70e-03 | 101 | 148 | 4 | C0033975 | |
| Disease | BMI-adjusted waist-hip ratio, sex interaction measurement, age at assessment | 1.96e-03 | 105 | 148 | 4 | EFO_0007788, EFO_0008007, EFO_0008343 | |
| Disease | renal cell carcinoma (biomarker_via_orthology) | 2.19e-03 | 14 | 148 | 2 | DOID:4450 (biomarker_via_orthology) | |
| Disease | triglyceride measurement, intermediate density lipoprotein measurement | 2.40e-03 | 111 | 148 | 4 | EFO_0004530, EFO_0008595 | |
| Disease | platelet storage pool deficiency (implicated_via_orthology) | 2.51e-03 | 15 | 148 | 2 | DOID:2223 (implicated_via_orthology) | |
| Disease | Situs ambiguus | 2.51e-03 | 15 | 148 | 2 | C0266642 | |
| Disease | Hemoglobin F Disease | 2.51e-03 | 15 | 148 | 2 | C0019025 | |
| Disease | R-6-hydroxywarfarin measurement | 2.65e-03 | 114 | 148 | 4 | EFO_0803327 | |
| Disease | antihyperlipidemic drug use measurement | 2.73e-03 | 115 | 148 | 4 | EFO_0803367 | |
| Disease | total lipids in large LDL | 2.97e-03 | 57 | 148 | 3 | EFO_0022163 | |
| Disease | cholesterol in large LDL measurement | 2.97e-03 | 57 | 148 | 3 | EFO_0021901 | |
| Disease | extrahepatic cholestasis (biomarker_via_orthology) | 3.23e-03 | 17 | 148 | 2 | DOID:13619 (biomarker_via_orthology) | |
| Disease | very low density lipoprotein cholesterol measurement, phospholipids:total lipids ratio | 3.58e-03 | 291 | 148 | 6 | EFO_0008317, EFO_0020946 | |
| Disease | Idiopathic hypogonadotropic hypogonadism | 3.63e-03 | 18 | 148 | 2 | C0342384 | |
| Disease | left ventricular mass | 3.63e-03 | 18 | 148 | 2 | EFO_0009289 | |
| Disease | urolithiasis | 3.94e-03 | 63 | 148 | 3 | MONDO_0024647 | |
| Disease | mood instability measurement | 4.01e-03 | 128 | 148 | 4 | EFO_0008475 | |
| Disease | Chronic myeloproliferative disorder | 4.04e-03 | 19 | 148 | 2 | C1292778 | |
| Disease | facial attractiveness measurement | 4.04e-03 | 19 | 148 | 2 | EFO_0009892 | |
| Disease | pulse pressure measurement | AMPD3 SHROOM3 MYO1C CNTRL MRPS27 HEATR5A RABGAP1 CCDC141 PLXDC2 PIK3C2A NFE2L2 TET1 ULK4 QSOX2 NIN | 4.38e-03 | 1392 | 148 | 15 | EFO_0005763 |
| Disease | renal system measurement | 4.47e-03 | 20 | 148 | 2 | EFO_0004742 | |
| Disease | phospholipids:total lipids ratio, intermediate density lipoprotein measurement | 4.68e-03 | 67 | 148 | 3 | EFO_0008595, EFO_0020946 | |
| Disease | prothrombin time measurement | 4.93e-03 | 21 | 148 | 2 | EFO_0008390 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| KQQKDLSEDHSSLLL | 111 | P07306 | |
| HKKKDLLSDNGSESL | 1476 | O94986 | |
| TAELTIAKDQLKSLH | 991 | Q7Z7A1 | |
| ALTSKLEHKDLNISV | 386 | Q8IUX8 | |
| KSAVADKHELLSLAS | 221 | O15372 | |
| LQSEAFKKHSLDLLS | 346 | Q8N998 | |
| SGELLAKNLSHLDTV | 31 | Q9UNS2 | |
| LIHAAKLNASLKTLE | 286 | Q96RT6 | |
| KILDKLELSLIHSRG | 1646 | Q8TDI0 | |
| SHSNKKLLSSLGIDT | 721 | Q6ULP2 | |
| ASHTANKEEKSLLEL | 866 | P35606 | |
| DESLKDKLSKLNIHS | 301 | Q9NXL2 | |
| EKLLNLSHSKSLSAL | 71 | Q7Z2Y8 | |
| HKLLAEALESQTLLG | 386 | P57764 | |
| SKELAEATKTLLHSL | 251 | O95477 | |
| LKANGEIKHVSSLLA | 606 | Q5M775 | |
| ASDHQKSLEDLKATL | 621 | Q9UDT6 | |
| KELASALKSALSGHL | 81 | P07355 | |
| AKGLNKSASLVHLSL | 141 | Q5JTW2 | |
| LATKHLKEGGLLTLA | 121 | P09417 | |
| KELASALKSALSGHL | 81 | A6NMY6 | |
| HAFDSLSGISLQKKL | 246 | Q5RIA9 | |
| GKLKHEDTNLASSTL | 291 | P49407 | |
| LDGKLKHEDTNLASS | 286 | P36575 | |
| IQDLNLSLSHLALKG | 736 | Q9H324 | |
| LSLSHLALKGDQESL | 741 | Q9H324 | |
| LTADNISHGLLLKKS | 601 | Q01432 | |
| KLQKGHVSLAAELSK | 3046 | P49792 | |
| LKDHTSGSKLTQLKI | 751 | Q8NDT2 | |
| KEASLLDLKEHASSL | 671 | Q8IUD2 | |
| AHKSLAGAELKTLKD | 341 | Q6ZRP7 | |
| LHGNSLSKLRDLSKL | 701 | Q6ZRR7 | |
| KIRLLGDDLKHESLS | 596 | Q86VD1 | |
| SSLAGALGKLKHSQD | 336 | Q9H8H0 | |
| LLIDLSKGTQHLKSI | 1676 | Q9H1A4 | |
| ETTHKASILLNGKLK | 1721 | Q8N7Z5 | |
| SIEDIKLKLTHLGTA | 181 | Q8TDY2 | |
| LGLLKTSKDDLLLTD | 761 | Q9Y3P9 | |
| ALSDLFKHLAKIGLS | 4126 | Q9NU22 | |
| LALNIDKTKGVLISH | 4151 | Q9NZR2 | |
| HGLSSAVKLKLLLGT | 46 | Q9H3P2 | |
| DLFEKLKITLGLLHS | 2441 | Q8IWI9 | |
| LSAHKDNLGTTIKLV | 431 | Q8N201 | |
| VDLLAGKSKDIALHL | 216 | O00214 | |
| VHELKKLNLSSNGIE | 291 | Q8N6Y2 | |
| HKLLAQLLGTSEEDS | 141 | Q9HB07 | |
| LLVSTLDGSLHALSK | 41 | Q76MJ5 | |
| LASLNGLEVHLKETL | 576 | Q9NQG7 | |
| QLKENLHSGIKSLED | 611 | Q8IY21 | |
| HAFDSLSGISLQKKL | 246 | Q8IUF1 | |
| HAFDSLSGISLQKKL | 246 | Q9BRT8 | |
| LLSAHLLSKKAGVEV | 126 | Q9BV94 | |
| LLALLKKHSGSGENT | 221 | Q8NGD0 | |
| TLENDIKGKLLDILH | 866 | O00443 | |
| LDILHKDSSLGLSKE | 876 | O00443 | |
| NDKSLHLLKKQLSTL | 546 | Q16236 | |
| LKILAIHGLISKDSL | 326 | P25025 | |
| KHGELKTKSIDLLDL | 21 | Q8N136 | |
| NLKKLTLLVVSGDHL | 281 | Q9BYS8 | |
| TLSQKFGSSDHLEKL | 171 | Q9H8J5 | |
| KFVKLHTLGDNLLDS | 236 | P07942 | |
| LLKGSLSSKEHINDL | 731 | Q8IWU2 | |
| SLETLKALLEVNKGH | 391 | Q13421 | |
| SLTQEILSHLGLASK | 11 | O76027 | |
| VTKKDLENLGLTHLI | 376 | Q9BSC4 | |
| KSNVESALSHGLKSL | 431 | Q76FK4 | |
| LEGKKSLSLSAKTHN | 676 | Q76FK4 | |
| LLDSHTGNLLTNEKL | 76 | Q9UN67 | |
| AAKAELALELHKTQG | 1321 | O95613 | |
| LSSHLGAVESEKQKL | 81 | Q9H0B6 | |
| SLLLDTLLGTKHVDS | 6 | Q8NHR9 | |
| TLLGTKHVDSAALIK | 11 | Q8NHR9 | |
| VEGLSDLRLELHSKK | 171 | Q96A65 | |
| GLTHTLKIKDARLSD | 381 | Q8N9C0 | |
| GLILLKLKNDHGSAT | 676 | Q8N9C0 | |
| ILEQLLDSIKHTKGA | 801 | Q86XA9 | |
| LEIGSSQDETKKLLH | 51 | Q6ZP82 | |
| GLKTHLDQLDLQISK | 91 | Q5SW24 | |
| STLDNSLHKDLLGAI | 1216 | Q9BZ29 | |
| LLKSKDASLVTNEDH | 766 | P49454 | |
| TEDHSASLKKALLII | 401 | Q5THR3 | |
| ANLKIDHLEKETSLL | 736 | O15078 | |
| DEKRLTLGHSKLDLI | 716 | Q9BQN1 | |
| AKSHKLTLLSSELEQ | 136 | Q53HC0 | |
| IKHLDDLKGTFAQLS | 76 | P69891 | |
| SLLGLIHKLKGEVSD | 441 | Q5T764 | |
| HAFDSLSGISLQKKL | 246 | Q5JTY5 | |
| HAFDSLSGISLQKKL | 246 | Q4V339 | |
| LKTSNLLLSHAGILK | 551 | Q9UQ88 | |
| LLDTKSTDRKQTLLH | 851 | Q96PY5 | |
| KKSADSLGKLELQHI | 1056 | Q99698 | |
| KTLKSDLSHTSLLEN | 186 | Q8TEP8 | |
| LAKLSLHSSNKEGIL | 256 | Q502W7 | |
| ALLSKKGLLSTLEDA | 1546 | Q05BV3 | |
| LHSTSAQVDDLKAKL | 3076 | Q9NYC9 | |
| IKHLDDLKGTFAQLS | 76 | P69892 | |
| LLDHLKGILDSLLTQ | 411 | Q9BRP7 | |
| QKLSSEIRHLLTLKD | 316 | Q9NQZ2 | |
| SNLEETLLLHEKSLK | 546 | A6NIM6 | |
| QLLSGAGEHLKSDLL | 286 | P35580 | |
| KTLHLETLKALLEGL | 71 | Q5VWM6 | |
| RKSHSLDLNISEKLT | 226 | Q86T96 | |
| STADLHQKLGKAIEL | 81 | Q8IVI9 | |
| LLDSHTGNLLTNEKL | 76 | Q9Y5E1 | |
| HAAKLNASLKTLEGE | 926 | Q96PC5 | |
| AHISSEAKDLISKLL | 341 | Q9BUB5 | |
| LALLHKDTRLSSGKL | 71 | Q504T8 | |
| ALHSKLQALGKIESE | 336 | Q92552 | |
| SGSLNHAASKKLDLE | 366 | P49591 | |
| DNLLLDSKGHVKLSD | 216 | Q15208 | |
| GATQHEAEALSLKLK | 4306 | Q8WXH0 | |
| SLLSDQILELKSSHK | 931 | Q8N4C6 | |
| KTLHLETLKALLEGL | 71 | Q5SWL7 | |
| HGLKGLNSKLLDIRS | 196 | P51665 | |
| ENLIEKGSNLHEKTL | 1476 | Q5UIP0 | |
| LEKETKSQSALAHAL | 1331 | Q9Y2K3 | |
| SGKDKDLVLGLSHLN | 186 | Q9NPR9 | |
| LDNLLLTKTGKLFHI | 746 | Q8NEB9 | |
| STLLKHEQTLETFKL | 686 | P98174 | |
| LKAALDHKADIIGLS | 816 | Q99707 | |
| DTKIALHLKDNGAST | 426 | Q6UX71 | |
| THKLETLQEAKGSLL | 1791 | Q8TF72 | |
| KTLHLETLKALLEGL | 71 | O95521 | |
| IDEKSLIKGKTHSQL | 221 | O00186 | |
| GLKKKLSDLQTQLSH | 251 | P19387 | |
| QSHLEDLKKTLLDSL | 811 | Q5JTH9 | |
| LKFLGLSTTHLEKSS | 141 | Q15399 | |
| LDEKQLAKLHTKTGL | 166 | Q9Y566 | |
| HELTQKTQDLKLSIG | 121 | Q8IW75 | |
| DSLSLFHLKTESNGK | 1261 | Q8NFU7 | |
| DKAFLTSHKGILLET | 26 | Q96DZ9 | |
| NHLLKALETSKADLE | 786 | Q86XI2 | |
| LSALGSQAHLSKEDK | 166 | Q08117 | |
| SSLKHLDLSSNLLKT | 736 | Q9NR97 | |
| GSLKQSILSSELLDH | 446 | Q96HI0 | |
| EKIKFDAGTLLLSTH | 31 | Q86VN1 | |
| LDSKAIAKQLGISSH | 1346 | Q8IZQ1 | |
| LQESNGHLISKTKDL | 76 | O95210 | |
| LLSRHLEEKQLSEGK | 1126 | Q8TEQ6 | |
| SLEGLHTKLGNIKTL | 346 | Q9Y2I1 | |
| AHLLEKGKSEELLSA | 281 | P16471 | |
| GLKVKLSDASHLSKE | 1096 | O15014 | |
| LSHELKISAKELLFG | 46 | Q3MJ13 | |
| TKHDVLLATLKSNLS | 41 | Q9C0B7 | |
| KNTEGALDLLKKLHS | 21 | O75764 | |
| LSSIGELKHALSDKA | 381 | Q8IWU9 | |
| LKLTLSKAGQEHLLR | 6 | Q16222 | |
| ISLLADTKLDLHLKG | 1676 | P78527 | |
| DTKLDLHLKGQAVTL | 1681 | P78527 | |
| SNGLKKKSLDHSGAL | 66 | Q96HH6 | |
| KKIGVLSLESLHAST | 1911 | Q7Z7G8 | |
| LKNHELSGLNKEELA | 121 | Q7Z2W4 | |
| TVLLAANLTGSHKLK | 276 | Q53EQ6 | |
| SSKDGKLLAATLLLA | 41 | Q9Y275 | |
| FKSHSSLEGLLKALS | 51 | Q9UHF0 | |
| AELLKDVLKNHAVSS | 871 | Q14669 | |
| DSTGDNLLLKHLFQK | 416 | Q5H9R7 | |
| IKRLGDHLAEKTSSL | 566 | Q69YN4 | |
| SYKSGKLHTLENLLE | 2211 | Q68DK2 | |
| RKHEIDGNALLLLKS | 371 | Q8N228 | |
| KLDLLCKTSHLSDTG | 161 | Q9HAD4 | |
| EKHLESLKNAGSLLR | 1231 | Q96C45 | |
| AHLKKLDLSGNDLSG | 336 | Q15048 | |
| LDLSNSKLHASSVKG | 731 | Q86W25 | |
| SELLITKAKNGHLAV | 1041 | O00159 | |
| SEKEENILSLSLKHL | 616 | Q86UW6 |